Status:
COMPLETED
Bleeding in Partial Upper Hemisternotomy Versus Full Sternotomy Aortic Valve Replacement
Lead Sponsor:
Karolinska University Hospital
Collaborating Sponsors:
Karolinska Institutet
Conditions:
Aortic Valve Stenosis
Heart Valve Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a single-center, open-label, randomized controlled trial. Patients scheduled for aortic valve replacement (AVR) at Karolinska University Hospital in Stockholm, Sweden will be eligible. One-hun...
Eligibility Criteria
Inclusion
- ≥ 18 years of age
- Severe aortic stenosis defined as aortic valve area of less than 1 cm2 or index area of 0.6 cm2/m2 by echocardiography
- Referred for medically indicated aortic valve replacement
- Sinus rhythm
- Provide written informed consent
Exclusion
- Inclusion in other trial
- Left ventricular ejection fraction less than 0.45
- Presence of any coexisting severe valvular disorder
- Previous cardiac surgery
- Urgent or emergent surgery
Key Trial Info
Start Date :
November 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02272621
Start Date
November 1 2013
End Date
October 1 2020
Last Update
June 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiothoracic Surgery, Karolinska University Hospital
Stockholm, Sweden